Post-traumatic Stress Disorder Treatment Market size is estimated at USD 17.7 billion in 2024 and is predicted to reach USD 35.1 billion by the end of 2037, expanding at a CAGR of 5.4% during the forecast period, i.e., 2025-2037. In 2025, the industry size of PTSD treatment is assessed at USD 18.6 billion.
The PTSD treatment market is expanding mainly due to the growing advancements in therapies and the increasing prevalence of the condition. In 2024, the World Health Organization (WHO) stated that PTSD is projected to have affected 3.9% of people worldwide at some point in their lives. There is a rising prevalence of PTSD due to factors such as rising global conflicts, natural disasters, and the growing awareness of mental health issues.
Growing advancements in therapeutic options, including pharmacological treatments and evidence-based therapies such as cognitive behavioral therapy (CBT) and eye movement desensitization and reprocessing (EMDR), are also contributing to post-traumatic stress disorder (PTSD) treatment market growth. Additionally, increased investment in mental health initiatives and destigmatization of mental health care further enhance treatment accessibility and demand. For instance, the WHO's Special Initiative for Mental Health, neurological, and substance use conditions aims to address and move people with these illnesses toward universal health care. The initiative covers nine countries across six regions: Argentina, Bangladesh, Ghana, Jordan, Nepal, Paraguay, the Philippines, Ukraine, and Zimbabwe.
As of 2023, more than 52 million people had access to newly available local services. This massive expansion was achieved with modest financial investments; the total expenditures for the initiative so far are accounted to be USD 25 million. Thus, for every USD 1 million spent, more than two million people gain access to newly available mental health services in their areas.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.4% |
|
Base Year Market Size (2024) |
USD 17.7 billion |
|
Forecast Year Market Size (2037) |
USD 35.1 billion |
|
Regional Scope |
|
Demographics (Adult, Children)
In post-traumatic stress disorder (PTSD) treatment market, adult segment is expected to account for more than 84.7% revenue share by the end of 2037. Adults, especially those exposed to trauma, represent a substantial portion of PTSD cases, driving demand for effective treatments. The prevalence of PTSD among adults is considered to be on the higher side. According to the American Psychiatric Association, about 3.5% of adults in the U.S. experience PTSD each year. Teenagers between the ages of 13 and 18 have an 8% lifetime frequency of PTSD. One in every eleven people is predicted to have a PTSD diagnosis at some point in their lives. PTSD affects women twice as frequently as men.
Moreover, as awareness of mental health issues rises, adults are more likely to seek treatment, breaking down barriers and reducing stigma. Also, the popularity of telehealth has made accessing PTSD treatment more convenient for adults, further driving PTSD treatment market growth.
Drug Class (Antidepressants, Antipsychotics, Anti-anxiety)
Antidepressants segment is anticipated to dominate post-traumatic stress disorder treatment market share of around 48.2% by the end of 2037. SSRIs (selective serotonin reuptake inhibitors) such as sertraline-containing Zoloft and paroxetine-containing Paxil are often prescribed for PTSD, demonstrating effectiveness in reducing symptoms, which increases their use. Antidepressants can help with symptoms such as depression, anxiety, and sleep difficulties. They function by controlling the brain's levels of specific neurotransmitters, such as norepinephrine and serotonin, which can be out of balance in PTSD sufferers.
Distribution Channel (Hospital Pharmacy, Retail Pharmacy)
By the end of 2037, retail pharmacy segment is anticipated to capture post-traumatic stress disorder treatment market share of around 63.6%. Treatment for post-traumatic stress disorder requires both short- and long-term pharmacological assistance, which promotes the expansion of retail pharmacies. Furthermore, retail pharmacists are comfortable dispensing major drugs, particularly in-home care settings. Additionally, retail pharmacies often engage in health promotion activities about, raising awareness about PTSD and available treatments, which can lead to more patients seeking help.
Our in-depth analysis of the post-traumatic stress disorder (PTSD) treatment market includes the following segments
|
Demographics |
|
|
Drug Class |
|
|
Distribution Channel |
|
North America Market Statistics
The post-traumatic stress disorder (PTSD) treatment market in North America is anticipated to hold the largest share of 40.7% by the end of 2037. The market growth is expected on account of the high rate of PTSD prevalence and the rising need for mental health care. PTSD affects a significant portion of population in the region, including veterans, first responders, and survivors of trauma, leading to increased demand for effective treatments.
The PTSD treatment market is expanding in the U.S. due to several factors, including rising government financing for mental health programs, increased awareness of the value of mental health, and an increase in the number of mental health practitioners. Also, there is a rising shift towards positivity among people regarding mental health. According to a 2019 survey by the American Psychological Association, 87% of adults in the U.S. concur that having a mental health illness is nothing to be ashamed of, and 86% stated that they think people with mental health illnesses are capable of recovering.
In Canada, the funding of mental health services and programs has increased since the government declared mental health a high priority. For instance, in 2023, the Canadian Institutes of Health Research (CIHR) funded 25 research projects with about USD 5 million to investigate current norms, best practices, and policies for providing mental health and drug-use services to teenagers, children, and young people. Furthermore, the market is expanding due to the rising demand for mental health services and the availability of cutting-edge therapies such as virtual reality therapy.
Europe Market Analysis
The PTSD treatment market in Europe will hold the second-largest revenue share during the forecast period. The market is growing in the region owing to the increasing incidences of PTSD and surging demand for mental health services. For instance, the majority of people in Europe roughly two-thirds have at least one traumatic incident in their lifetime.
The UK post-traumatic stress disorder (PTSD) treatment market is expanding due to several factors, including rising government funding for mental health initiatives, expanding awareness of the value of mental health, and the accessibility of cutting-edge therapies that include, Eye Movement Desensitization and Reprocessing (EMDR). The government stated that by April 2024, an additional USD 2.57 billion in funding will be provided annually to expand and reform mental health services in England, enabling 2 million more individuals to receive the necessary mental health assistance.
In Germany, improving the nation's mental health and quality of life are top priorities. The need for efficient therapies is driven by the emphasis on mental health as a vital aspect of total well-being. The industry is expanding due to the initiatives to improve mental health care and promote wellbeing.
The PTSD treatment market is extremely fragmented, with both small enterprises and large companies in competition. To treat PTSD symptoms, pharmaceutical firms are developing and marketing both new and well-known drugs, like anxiolytics and antidepressants. The market is competitive and dynamic, with a constant focus on improving patient outcomes and innovation.
Some of the prominent players include:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?